The atypical serine/threonine kinase mTOR (mammalian target of rapamycin) is a central regulator of cell growth and metabolism. mTOR is part of two multisubunit signalling complexes, mTORC1 and mTORC2. Although many aspects of mTOR signalling are understood, the lack of high-resolution structures impairs a detailed understanding of complex assembly, function and regulation. The structure of the kinase domain is of special interest for the development of mTOR inhibitors as anti-cancer agents. A homology model of the mTOR kinase domain was derived from the structure of PI3Ks (phosphoinositide 3-kinases). More recently, the crystal structure of the catalytic domain of human mTOR was determined, providing longawaited structural insight into the architecture of mTOR. Interestingly, the homology model predicted several aspects of the crystal structure. In the present paper, we revisit the homology model in the context of the now available crystal structure of the mTOR kinase domain.
Introduction
Cells co-ordinate and regulate growth through a network of signalling pathways. Signal transduction is based on the modification of substrate activity by phosphorylation. In eukaryotes, phosphorylation occurs at conserved serine, threonine or tyrosine residues and is mediated by a large variety of PKs (protein kinases) [1, 2] . The human genome encodes 518 putative kinases that can be classified into seven major families on the basis of their evolutionary relationship [3] . The canonical kinase domain exhibits a characteristic architecture consisting of a smaller N-terminal lobe (N-lobe) and a larger C-terminal lobe (C-lobe) [4] . Upon activation, PKs catalyse the transfer of the γ -phosphate group from ATP to a hydroxy group on the substrate [5] . The kinase active site is located in the cleft between the N-and C-lobes and is formed by residues from a conserved ATP-binding pocket and a catalytic loop. In the ATP-binding pocket, the adenine portion of ATP is bound through hydrophobic interactions, whereas the phosphates are recognized by polar contacts. Kinase activity is regulated by the phosphorylation state of the activation loop [6] . Moreover, the activation loop provides a catalytic residue and forms part of the substrate-binding site.
The serine/threonine kinase mTOR (mammalian target of rapamycin) is a PIKK (phosphoinositide 3-kinase-related kinase) and belongs to the group of atypical PKs [1] . mTOR interacts with several proteins to form two functionally and structurally distinct multisubunit signalling complexes termed mTORC1 (mTOR complex 1) and mTORC2. The two mTORCs regulate several important processes, e.g. protein, lipid and nucleotide synthesis, autophagy and apoptosis, via distinct signalling pathways (for reviews, see [7] [8] [9] ). mTORC1 responds to growth factors, nutrients and cellular energy. The best-characterized mTORC1 substrates are S6K (S6 kinase) and 4E-BP1 (eukaryotic initiation factor 4E-binding protein 1). mTORC2 signalling is less well characterized. This complex is controlled by growth factor signals and is activated by interaction with the ribosome [10, 11] . mTORC2 substrates include the AGC kinase family [12] members Akt (also known as PKB), PKCα and SGK1 (serum-and glucocorticoid-induced protein kinase 1) [13] . Considering the essential roles of mTORC1/2 in cell growth and metabolism, it is not surprising that deregulation of mTOR signalling is linked to a variety of human diseases, including metabolic disorders, cancer and neurodegeneration [7] . mTORC1 and mTORC2 share the mTOR catalytic subunit and mLST8 (mammalian lethal with sec-13 protein 8). mLST8 is a Gβ-like protein and consists entirely of WD40 repeats that form a seven-bladed β-propeller [14, 15] . mLST8 interacts directly with the kinase domain of mTOR and is essential for mTORC2 activity. The distinctive subunit of mTORC1 is raptor (regulatory associated protein of mTOR). Raptor is a multidomain protein comprising an N-terminal RNC (raptor N-terminal conserved) domain, several central HEAT repeats [named after huntingtin, elongation factor 3, regulatory subunit A of PP2A (protein phosphatase 2A) and TOR1 (target of rapamycin 1)] and a C-terminal WD40 β-propeller [16, 17] . Raptor is thought to act as a scaffold protein for mTORC1 assembly and to mediate substrate binding [18, 19] . The unique characteristics of mTORC2 are its subunits rictor (rapamycin-insensitive companion of mTOR) and protor (protein observed with rictor; also known as PRR5) [20] . Rictor is an armadillo repeat-containing protein, which supposedly functions as a core for mTORC2 assembly and as an adaptor for substrate binding [21] . Protor has also been implicated in the modulation of mTORC2 activity and specificity, but has no known structural elements [22] .
On the structural level, mTOR and other PIKKs are characterized by a conserved C-terminal kinase domain preceded by an N-terminal FAT (FRAP/ATM/TTRAP) domain and followed by a C-terminal FATC (FAT Cterminal) domain. The kinase domain of PIKK family kinases is structurally related to the catalytic domain of PIKs (phosphoinositide kinases) which, in turn, show structural similarity to the canonical kinase domain of typical PKs [3, 23] . Structural homology searches furthermore suggest that the N-terminal part of mTOR has predominantly helical secondary structure [24] . The first ∼1350 residues of mTOR probably consist entirely of HEAT repeats [25] followed by the ∼650-residue FAT domain that comprises several TPRs (tetratricopeptide repeats) [26] . Both types of repeats form extended superhelical domains important for protein-protein interactions [27] .
Until recently, high-resolution structural information was available only for two small regions of mTOR, the FRB [FKBP12 (FK506-binding protein 12)/rapamycin-binding] domain [28] of human mTOR and the FATC domain of yeast TOR1 [29] . On the sequence level, the FRB domain is directly adjacent to the kinase domain and forms a fourhelix bundle. Furthermore, the FRB domain is responsible for the sensitivity of mTORC1 towards rapamycin, a widely used anti-proliferative and immunosuppressant macrolide. Rapamycin forms a gain-of-function complex with the peptidylprolyl cis-trans isomerase FKBP12 and this complex binds directly to the FRB domain to inhibit mTORC1 signalling [28] . The NMR structure of the TOR1 FATC domain revealed an all-helical structure consisting of a helix followed by a sharp turn that is stabilized by a disulfide bond [29] .
A major breakthrough in the understanding of the atomic structure and the mechanism of action of mTOR has now been reported by Yang et al. [30] . They determined the structure of an mTOR fragment in complex with mLST8 in the apo-state as well as with ATPγ S (adenosine 5-[γ -thio]triphosphate, a non-hydrolysable ATP analogue), MgF 3 − (a transition state mimic) and several mTOR inhibitors. The crystallized portion of mTOR comprised the FAT, FRB, kinase and FATC domains (residues 1376-2549), but lacked the predicted N-terminal HEAT repeats (residues 1-1375, hence mTOR N ). The structure confirmed a bilobal architecture of the kinase core domain that is characteristic of PKs and PIKs (Figure 1 ). The N-lobe of the kinase domain starts with a long helix (kα1) followed by the FRB domain which is actually inserted in the kinase domain sequence [30] . The FRB domain folds into an independent structure protruding from the N-lobe, thereby restricting access to the catalytic cleft. The C-lobe contains a helix-loop-helix insertion (LBE, for mLST8-binding element) which is the binding site for mLST8. Binding of mLST8 consequently results in a further restriction of the catalytic cleft from the Clobe side. Another important finding is that the FATC domain is an integral part of the C-lobe and indispensable for kinase activity as it interacts with the activation loop. Interestingly, the conformation of the activation loop was not significantly changed in the mTOR N -mLST8 complex upon binding of ADP, Mg 2 + and MgF 3 − , suggesting that the kinase domain is generally in an intrinsically active conformation. This active conformation is stabilized by the FAT domain which clamps around the kinase domain, contacting the N-and C-lobes on sites opposite of the catalytic cleft ( Figure 1 ). The FAT domain was furthermore shown to comprise a total of 28 α-helices from the TPR and HEAT repeat families. For a more detailed description of the mTOR N -mLST8 complex structures, the reader is referred to the original publication [30] .
Before the crystal structure was available, attempts had been made to model the catalytic domain and the ATPbinding site of mTOR, on the basis of structural homology with PI3Ks (phosphoinositide 3-kinases) [31, 32] . The model of the mTOR kinase domain included the FRB and kinase domains (residues 1879-2549) and was built based on the then available structure of PI3KCγ [31, 33] . The homology model identified defining sequence motifs in the mTOR kinase domain that were highly conserved across species and between the PIK and PIKK families. Moreover, the ATPbinding pocket was described with great accuracy anticipating key functions of the conserved residues. Additionally, the model predicted the location of activating mutations that can now be mapped on to the crystal structure of mTOR NmLST8.
We have analysed the structure-function relationships of conserved sequence motifs identified in the homology model that can now be validated by the crystal structure of mTOR N -mLST8.
Conserved motifs localize to the active site, the catalytic loop and the ATP-binding pocket
ATP-binding pocket
The homology model identified K 2187 GHEDLRQD 2195 as a highly conserved sequence motif in the active site of the mTOR kinase domain (indicated as 'K2187 loop' in Figures 1, 2 and 3) [31] . This motif comprises the catalytic residue Lys 2187 that was suggested to contact the α-phosphate group of ATP [31] . In the structure of the mTOR N -mLST8-ATPγ S complex (PDB code 4JSP), Lys 2187 is located at the very end of the kβ5 strand and could contact the α-and/or β-phosphate groups of ATP (Figure 2A ). Another conserved residue that was correctly predicted to contact the triphosphate moiety of ATP is Ser 2165 . Ser 2165 is located in the ATP-binding pocket and, as expected, its side-chain hydroxy group provides a hydrogen bond to O2β (Figure 2A (Figure 2A ). The small side chain of Gly 2188 , for instance, allows for the close packing of kα1, the first helix of the kinase domain. His 2189 donates a hydrogen bond to Gln 2167 , a conserved residue in the ATP loop, which in turn could contact O2β and O3γ . Glu 2190 is likely to orient the side chain of Lys 2187 . Asp 2191 contributes to the overall orientation of the GHEDL loop. Its side chain points away from the ATP-binding pocket and probably provides a polar contact for the side chain of Arg 2193 located at the N-terminal end of kα3a. Leu 2192 provides a binding site for the kβ7 strand, the residues of which form the hydrophobic pocket for the adenine ring (also see below for discussion of the G 2235 LIGW 2239 motif). The kα3a helix marks the beginning of the C-lobe and traverses its entire core. Consequently, kα3a is of central importance for the organization of the kinase domain (Figures 1 and 2B) Figure 2B ). A signature residue in the hydrophobic part of the ATPbinding pocket is Tyr 2225 ( Figure 2B ). Tyr 2225 is found at the hinge between the N-and C-lobes in a loop connecting kα3b and kβ6. The homology model correctly predicted the phenyl side chain to be in ∼4 Å (1 Å = 0.1 nm) distance to the N-6 amino group and perpendicular to the adenine ring.
The (Figures 2A and 2B ). Val 2240 is actually involved in the specific recognition of ATP as its peptide nitrogen donates a hydrogen bond to N-1 of adenine. Met 2345 and Leu 2354 are part of the N-lobe strands kβ9 and kβ10 respectively. Both residues contribute to the part of the hydrophobic pocket opposite of the G 2235 LIGW 2239 motif and can be replaced by other aliphatic residues in the PIKK family [31] .
Catalytic loop
The homology model described GLGD 2338 R 2339 H 2340 PS 2342 as the signature motif of the catalytic loop [31] (Figure 2A) . The mTOR N -mLST8 complex structure now shows that the arrangement of key catalytic residues (underlined) in the active site of mTOR superimposes with the active site of typical PKs suggesting a conserved catalytic mechanism [30] . Asp 2338 (Figure 2A ), for example, was correctly predicted to be the catalytic base that orients and activates the substrate hydroxy group for the nucleophilic attack [30, 31] [31] (Figure 3 ). Pro 2341 is located at the C-terminal end of the catalytic loop and forms a part of a hydrophobic core centred on Trp 2549 , the last residue of mTOR ( Figure 2C ). 
Activation loop, FATC and LBE domains
The crystal structure revealed that the mTOR activation loop is closely related to the canonical activation loop of PKs [5] . It has a typical length of ∼30 amino acids and also contains a short α-helix [30] . The loop is very well ordered owing to extensive contacts with the kα9b helix on one side and the FATC domain on the other ( Figure 2C ). The homology model defined two highly conserved sequence motifs in the activation loop of TOR proteins, the D 2357 F 2358 G 2359 motif at the N-terminal end and P 2372 E(K/R)(V/I)PFRL 2379 at the C-terminal end [31] . Asp 2357 was predicted to be a metal ligand, and in the complex structure, Asp 2357 is indeed found at 3.3 Å distance from an Mg 2 + ion (Figure 2A ). The peptide nitrogen of Gly 2359 donates a hydrogen bond to the side chain of Asp 2357 , thereby determining its orientation. Phe 2358 serves a structural role and acts as a hydrophobic stacking platform for the N-terminal end of the kα3a helix ( Figure 2C ). The entire P 2372 E(K/R)(V/I)PFRL 2379 sequence is closely associated with the FATC domain mainly via hydrophobic interactions.
The conformation of the activation loop is stabilized by extensive interactions with the mTOR FATC domain, emphasizing the importance of FATC for kinase activity [30, 35] . The FATC domain consists of a highly conserved Nterminal helix (kα11) followed by three short predominantly helical segments (kα12a, kα12b and kα12c) ( Figures 2C and  3) . Together, the FATC helices form the basal part of the C-lobe. The homology model could not reliably predict the FATC secondary structure because of low sequence conservation compared with PI3KCγ . However, several structurally important residues were identified. Gln 2524 in kα11, for instance, is located in the centre of an interaction network that organizes the kα8 and kα10 helices ( Figure 2C) . Gln 2524 provides a hydrogen bond to the side chain of Asp 2512 and the peptide oxygen of Lys 2507 (kα10). Additionally, Gln 2524 is in polar interaction distance with Arg 2408 (kα8). Arg 2408 , in turn, is part of a hydrogen-bond network at the hinge between the kinase and FATC domains and stacks between the kα10 and kα11 helices ( Figure 2C ). Lys 2507 is also a particularly interesting residue that was identified in the conserved K 2507 LT motif. The side chain of Lys 2507 is in hydrogen-bonding distance to the backbone oxygen of Tyr 2332 and the side chain of Glu 2363 . Glu 2363 is the first residue of the kαAL helix in the activation loop and Lys Multiple sequence alignment of the TOR kinase domain from several species. Highly conserved residues are shown in red (>70% conservation). Invariant residues are white in red boxes. The secondary structure of human mTOR N (PDB code 4JSP [30] ) is indicated. Conserved sequence motifs that were identified in the homology model are labelled (FRB domain, light blue; ATP loop, yellow; K2187 loop, blue; kα3a helix, rose; catalytic loop, green; activation loop, red; FATC domain, light green). Sequences of representative TOR proteins were retrieved from the UniProt database [39] (http://uniprot.org) and aligned using MUSCLE [40] . The alignment was further hand curated using Jalview 2.7 [41] . The final Figure was generated using ESPript [42] . activation loop. Interestingly, the equivalent lysine residue is acetylated in ATM (ataxia telangiectasia mutated) and acetylation is required for kinase function [36] . A putative acetylation of mTOR Lys 2507 would disrupt the hydrogenbonding interaction to Glu 2363 and could thereby increase the flexibility of the activation loop and eventually affect kinase activity.
The mTOR N -mLST8 complex structure revealed that the FATC domain is sandwiched between the activation loop on one side and the LBE insertion (2258-2296) on the other [30] . As anticipated by the homology model, the LBE sequence adopts a helix-loop-helix secondary structure. The mainly hydrophobic LBE/FATC interface is composed of residues from the FATC kα12a, kα12b and kα12c helical segments. Binding of mLST8 to the LBE insertion is supposed to stabilize the conformation of the FATC domain and to (indirectly) contribute to the orientation of the activation loop [30] .
At the beginning of the LBE insertion, the homology model highlights an R 2254 EKKK 2258 motif which contains the highly conserved residue Arg 2254 . In the crystal structure, this residue provides a hydrogen bond to the side chain of Asp 2298 and makes a polar contact to Glu 2264 in the first helix of the LBE insertion (kα4b). The E 2255 KKK 2258 sequence at the Cterminal end of kα4a is variable and was correctly predicted as solvent-exposed. 
Conserved motifs in the FRB and FAT domains of mTOR

FAT domain
The mTOR N -mLST8 complex structure finally provided crucial insights into the organization of the FAT domain. The 28 α-helices are arranged into discrete packages of TPR domains (helices α1-α22; TRD1, 1.5 repeats and TRD2/3, 4.5 repeats) and a HEAT repeat domain (helices α23-α28; HRD, three repeats). Together, the repeat domains form a clamp around the kinase domain and interact with conserved sequence patches in the N-and C-lobes [30] . Owing to the minimal sequence conservation between the FAT domains of PI3KCγ and mTOR, the homology model could not reliably predict the helical boundaries and their arrangement [31] . However, the model identified the conserved W 2304 LK motif that can now be mapped to the interface between TRD1 and the C-lobe. The W 2304 LK motif marks the C-terminal end of the kα5 helix and Trp 2304 is highly conserved in the TOR family. The aromatic side chain of Trp 2304 provides a stacking platform for the imidazole ring of His 1398 in the first helix of TRD1.
Conclusions
The accuracy of any homology model strongly depends on the sequence conservation between the target and template molecules as well as on the quality of the sequence alignment and the reference model [37, 38] . The largely correct prediction of the mTOR kinase domain provided by the homology model therefore reflects the structural conservation and evolutionary relationship of the PIK, PIKK and PK families. The FAT and FRB domains, however, could not be reliably modelled because these regions are more divergent and show rather low sequence identity [31] . The structures of mTOR-specific features such as the negative regulatory domain (residues 2437-2492) or the serine/threonine-rich loop sequence between kα21 and kα22 (residues 1814-1867) could not be modelled on the basis of homology and remain unresolved also in the experimental structure [30] . Nevertheless, the homology model identified several highly conserved sequence motifs in the mTOR kinase domain that are now confirmed to be involved in ATP binding, catalysis or to serve important structural roles. Moreover, the homology model revealed that activating mTOR mutations co-localize with oncogenic mutations in PI3KCα [31] . The now available crystallographic and biochemical evidence suggests a negative regulatory mechanism for the control of mTOR kinase activity [30] . This model is in accordance with hyperactivating mutations being localized to structural elements that restrict access to the active site and affect the FAT/kinase domain interface [30] .
Several docking studies analysed the binding of mTOR inhibitors in the ATP-binding pocket [31, 32, 34] . The cocrystal structures of mTOR N -mLST8 with Torin-2, PP242 and PI-103 now reveal that, although the overall orientation of the inhibitors in the binding pocket was predicted correctly, their detailed binding modes diverged from the docked models. Torin-2, for instance, was suggested to make several hydrogen-bond interactions, none of which were observed in the crystal structure [30, 34] . Rather, the experimental structure showed that the binding specificity and affinity of Torin-2 for mTOR results from predominantly hydrophobic and stacking interactions with conserved residues in the ATP-binding pocket. Binding of PP242, on the other hand, results in a local conformational change in the ATP pocket that could not be anticipated [31] . Therefore, although docking approaches can provide important input for inhibitor design and optimization, a crystallographic model validation remains imperative.
Future studies will focus on the further structural elucidation of mTOR and the atypical PK family. In particular, high-to medium-resolution structures of fulllength mTOR in complex with its binding partners should be insightful to understand complex assembly and regulation. Moreover, the structural analysis of mTOR complexes could further contribute to the understanding of substrate specificity and the different sensitivity of mTORC1 and mTORC2 towards rapamycin. The conserved structure and catalytic mechanism of PKs pose a major challenge in the design of specific inhibitors. The atomic structures of mTORC1 and mTORC2 could also contribute to the development of new anti-cancer drugs, e.g. by exploiting the interface between the kinase and FAT domain as pharmacophore space.
